Evaluation of telomerase activity in gingival fibroblasts of cyclosporine-treated patients

被引:1
作者
Biray, C. [1 ]
Nizam, N.
Gunduz, C.
Sonmez, S.
Cavdar, C.
Saglam, F.
Atilla, K.
Camsari, T.
机构
[1] Ege Univ, Sch Med, Dept Med Biol, TR-35100 Izmir, Turkey
关键词
D O I
10.1016/j.transproceed.2007.11.065
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Gingival overgrowth (GO) is a common side effect following administration of cyclosporin A (CsA). Various case reports have shown that squamous cell carcinomas could arise in GO induced by CsA and phenytoin. It is also known that human telomerase activated in about 90% of cancers is mainly composed of hTR, hTERT, and TPI. The aim of this study was to investigate the potential role of telomerase activity in the pathogenesis of CsA-induced GO. Included in the study were 9 patients on CsA: 4 with and 5 without GO. Gingival tissues were obtained during gingivectomy or flap procedures; gingival fibroblasts were cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10,000 U/mL penicillin, 10 mg/mL streptomycin, 2 mmol/L L-glutamine, and 10% heat-inactivated fetal bovine serum at 37 degrees C under a humidified 95% air virgule 5% CO2 atmosphere. Quantitative detection of hTERT mRNA was performed with the commercially available LightCycler Telo TAGGG hTERT Quantification Kit using real-time online PCR. The hTERT mRNA expression was positive in one patient, while hTERT mRNA expression was negative in the others. Because results indicated that there may be a relationship between CsA-induced GO and positive telomerase activity, detailed studies should be performed to confirm the present findings.
引用
收藏
页码:184 / 185
页数:2
相关论文
共 50 条
[31]   Cyclosporine A accumulation in human gingival fibroblasts. [J].
Mariotti, A ;
Manning, CJ ;
Hassell, T ;
Heft, A .
JOURNAL OF DENTAL RESEARCH, 1997, 76 :2046-2046
[32]   THE EFFECT OF CYCLOSPORINE ON HUMAN GINGIVAL FIBROBLASTS INVITRO [J].
BARTOLD, PM ;
VERNONROBERTS, B .
JOURNAL OF DENTAL RESEARCH, 1989, 68 (04) :543-543
[33]   LOW RED-CELL ARACHIDONIC-ACID IN CYCLOSPORINE-TREATED PATIENTS [J].
PHAIR, PG ;
POWELL, HR ;
MCCREDIE, DA ;
WALKER, RG ;
DAPICE, AJF .
CLINICAL NEPHROLOGY, 1989, 32 (02) :57-61
[34]   BONE-MINERAL CONTENT IN CYCLOSPORINE-TREATED RENAL-TRANSPLANT PATIENTS [J].
MASSARI, PU ;
GARAY, G ;
ULLA, MR .
TRANSPLANTATION PROCEEDINGS, 1994, 26 (05) :2646-2648
[35]   LYMPHOCYTE SUBPOPULATION MONITORING IN CYCLOSPORINE-TREATED PATIENTS FOLLOWING HEART-TRANSPLANTATION [J].
PELLETIER, LC ;
MONTPLAISIR, S ;
PELLETIER, G ;
CASTONGUAY, Y ;
HARVEY, P ;
DYRDA, I ;
SOLYMOSS, CB .
ANNALS OF THORACIC SURGERY, 1988, 45 (01) :11-15
[36]   CYCLOSPORINE-TREATED RENAL-TRANSPLANT PATIENTS HAVE ONLY PARTIAL INHIBITION OF CALCINEURIN PHOSPHATASE-ACTIVITY [J].
BATIUK, TD ;
PAZDERKA, F ;
HALLORAN, PF .
TRANSPLANTATION PROCEEDINGS, 1995, 27 (01) :840-841
[37]   SERUM POTASSIUM CONCENTRATIONS IN CYCLOSPORINE-TREATED AND AZATHIOPRINE-TREATED RENAL-TRANSPLANT PATIENTS [J].
FOLEY, RJ ;
HAMNER, RW ;
WEINMAN, EJ .
NEPHRON, 1985, 40 (03) :280-285
[38]   COLD ISCHEMIA TIME AND RENAL-ALLOGRAFT FUNCTION IN CYCLOSPORINE-TREATED PATIENTS [J].
EKLUND, B ;
HOCKERSTEDT, K ;
ISONIEMI, H ;
KORSBACK, C ;
AHONEN, J .
TRANSPLANTATION PROCEEDINGS, 1988, 20 (03) :442-443
[39]   EFFECTS OF ISRADIPINE ON RENAL-FUNCTION IN CYCLOSPORINE-TREATED RENAL TRANSPLANTED PATIENTS [J].
BERG, KJ ;
HOLDAAS, H ;
ENDRESEN, L ;
FAUCHALD, P ;
HARTMANN, A ;
PRAN, T ;
SOLBU, D .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1991, 6 (10) :725-730
[40]   Late prednisone withdrawal in cyclosporine-treated kidney transplant patients: A randomized study [J].
Hollander, AAMJ ;
Hene, RJ ;
Hermans, J ;
VanEs, LA ;
VanderWoude, FJ .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1997, 8 (02) :294-301